Mirae Asset Healthcare Fund - Growth - Regular Plan

Other Plans and Options
  • 1.5 %Nav, as on 23-01-2025

  • Previous Nav

  • Net Change on 23-01-2025

  • PersonalFN Rating

  • Assets (Cr.)

  • Expense Ratio

Fund Overview Growth | Regular Plan

  • Fund House

  • Launch Date

  • Benchmark

  • Minimum Investment (₹)

  • Minimum Addl Investment (₹)

  • Exit Load (%)

  • Minimum SIP Investment (₹)

  • Minimum STP Investment (₹)

  • Minimum SWP Investment (₹)

  • 52 Week Low Nav (₹)

  • 52 Week Low Nav Date

  • 52 Week High Nav (₹)

  • 52 Week High Nav Date

Fund Objective

The investment objective of the scheme is to seek to generate long term capital appreciation through investing in equity and equity related securities of companies benefitting directly or indirectly in Healthcare and allied sectors in India. The Scheme does not guarantee or assure any returns.

Fund Performance

Scheme Name 1-Month Return (%) 3-Month Return (%) 1-Year Return (%) 3-Year Return (%) 5-Year Return (%) Since Inception
Mirae Asset Healthcare Fund -Regular Growth -3.09 -3.06 26.95 17.64 26.57 22.13
BSE Health Care - TRI -2.12 1.04 31.49 21.61 25.84 15.97
BSE SENSEX - TRI -2.55 -4.28 10.07 10.40 14.44 13.44

Returns upto 1 year is Absolute, and above 1 year are Compounded Annualised

Peer Fund Comparison

Scheme Name Launch Date Ratings 1-Year Return (%) 3-Year Return (%) 5-Year Return (%) Expense Ratio (%) Assets (Cr.)
Mirae Asset Healthcare Fund -Regular Growth Jul 02, 2018 26.95 17.64 26.57 1.92 2,863.52
Nippon India Pharma Fund-Growth Plan-Growth Jun 05, 2004 21.35 19.23 25.77 1.80 8,914.89
ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund - Cumulative Option Jul 13, 2018 34.34 23.90 28.58 1.91 5,320.29
SBI HEALTHCARE OPPORTUNITIES FUND - REGULAR PLAN -GROWTH Jul 14, 1999 29.60 22.95 27.55 1.94 3,628.03
DSP Healthcare Fund - Regular Plan - Growth Nov 30, 2018 31.20 21.89 27.95 1.90 3,339.79
Tata India Pharma & Healthcare Fund-Regular Plan-Growth Dec 28, 2015 27.23 20.49 25.50 2.13 1,287.45

Fund Holdings as on 31-December-2024

  • Sun Pharmaceutical Industries Limited

  • Aurobindo Pharma Limited

  • Cipla Limited

  • Dr. Reddy's Laboratories Limited

  • Lupin Limited

  • Glenmark Pharmaceuticals Limited

  • Divi's Laboratories Limited

  • Apollo Hospitals Enterprise Limited

  • Krishna Institute Of Medical Sciences Limited

  • Torrent Pharmaceuticals Limited

  • Suven Pharmaceuticals Limited

  • Gland Pharma Limited

  • Syngene International Limited

  • Mankind Pharma Limited

  • Wockhardt Limited

  • JB Chemicals & Pharmaceuticals Limited

  • Alkem Laboratories Limited

  • Fortis Healthcare Limited

  • Sai Life Sciences Limited

  • IPCA Laboratories Limited

  • Zydus Lifesciences Limited

  • Aster DM Healthcare Limited

  • Onesource Specialty Pharma Limited **

  • Biocon Limited

  • Sagility India Limited

  • Neogen Chemicals Limited

  • Strides Pharma Science Limited

  • Ajanta Pharma Limited

  • SRF Limited

  • TREPS

  • Net Receivables / (Payables)

  • Suraksha Diagnostic Limited

  • Mirae Asset Liquid Fund - Direct Growth

  • Dr. Lal Path Labs Limited

View More

  • Pharmaceuticals & Drugs

  • Hospital & Healthcare Services

  • Business Support

  • Chemicals

  • Miscellaneous

View More

Fund Manager

  • Cash

  • Equity

  • MFU

View More

About Mirae Asset Healthcare Fund

Scheme Analysis

Mirae Asset Healthcare Fund is a Equity - Sectoral Fund - Pharma & Health Care fund and belongs to Mirae Asset Mutual Fund. It was launched on 02-Jul-2018 and currently has an AUM of ₹2,863.52 crore. Mirae Asset Healthcare Fund is benchmarked against BSE Health Care - TRI as primary index and BSE SENSEX - TRI as secondary index.

The NAV of Mirae Asset Healthcare Fund ended up ₹0.56(1.5%)yesterday to ₹37.702.

Among its top 3 holdings the fund has exposure to Sun Pharmaceutical Industries Limited, and

The Mirae Asset Healthcare Fund is managed by Vrijesh Kasera .

Fund House Contact

Unit 606, 6th Floor, Windsor Building, Off CST Road, Kalina, Santacruz (E), Mumbai - 400 098

022-67800300
022-67253940